January 25, 2022 – NutraNomics, Inc. (OTC: NNRX) is pleased to provide the following guidance related to its pending acquisition of DHS Development, Inc. dba The Plant.  NutraNomics’ capital investment will center on equipment and facility improvements as they pertain to Manufacturing & Cultivation infrastructure build-out in order to fulfill in-place and pending wholesale customer sales agreements, and to support the production of core products such as Cured and Live Concentrates, Crude, Distillates, Pre-Rolls, Capsules, Gummies, Tablets, Vape Cartridges, Topicals, Flower, as well as Contract Packaging.  Pending closure of The Plant’s acquisition, NutraNomics is committing up to $1M of leveraged interim capital for manufacturing assets necessary to serve immediate customer product demand.

“Through our strategic capital investment into critical elements of our manufacturing and cultivation operation, we are committed to the principles of optimal quality and cost-efficiency.  Our intelligent verticalization plan not only sets a solid foundation upon which to produce top quality products for our valued customers, but allows us to evolve our 27,000 sq. ft. production facility into other areas of unique product differentiation in conjunction with the addition of our 30,000 sq. ft. state-of-the-art cultivation operation,” says Jonathan Bishop, NutraNomics’ CEO.  Further details regarding terms of the Acquisition will be disclosed following formal closure of the Acquisition slated for mid-February.